Karimabad, M.N.; Kounis, N.G.; Hassanshahi, G.; Hassanshahi, F.; Mplani, V.; Koniari, I.; Hung, M.-Y.; Nadimi, A.E.
The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review. Vaccines 2021, 9, 1224.
https://doi.org/10.3390/vaccines9111224
AMA Style
Karimabad MN, Kounis NG, Hassanshahi G, Hassanshahi F, Mplani V, Koniari I, Hung M-Y, Nadimi AE.
The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review. Vaccines. 2021; 9(11):1224.
https://doi.org/10.3390/vaccines9111224
Chicago/Turabian Style
Karimabad, Mojgan Noroozi, Nicholas G. Kounis, Gholamhossein Hassanshahi, Farzaneh Hassanshahi, Virginia Mplani, Ioanna Koniari, Ming-Yow Hung, and Ali Esmaeili Nadimi.
2021. "The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review" Vaccines 9, no. 11: 1224.
https://doi.org/10.3390/vaccines9111224
APA Style
Karimabad, M. N., Kounis, N. G., Hassanshahi, G., Hassanshahi, F., Mplani, V., Koniari, I., Hung, M.-Y., & Nadimi, A. E.
(2021). The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review. Vaccines, 9(11), 1224.
https://doi.org/10.3390/vaccines9111224
